Molbio Diagnostics Ltd (MOLBIO)
₹1,274.00
Price history
Molbio Diagnostics is an innovative point- of-care (POC) diagnostics company that develops affordable, rapid, and accurate diagnostic solutions for infectious and non-communicable diseases. Its flagship product, Truenat, is a portable, battery-powered PCR testing platform that delivers results within an hour. Designed for use in resource-limited settings, it enables quick and decentralised disease diagnosis at the point of care. Through its wholly owned subsidiary, Bigtec Labs, Molbio has strong research and development capabilities focused on creating diagnostic platforms for point-of- care (POC) testing. From product development to large-scale deployment, the company aims to improve access to reliable and affordable healthcare for everyone. https://www.molbiodiagnostics.com/wp-content/uploads/2026/08/Molbio-Diagnostics-Limited-Red-Herring-Prospectus.pdf#page=215 #}
Financials
| Jun 2025 | Mar 2026 | Jun 2026 | Trend | |
|---|---|---|---|---|
| Sales | 100 | 561 | 408 | |
| Expenses | 116 | 402 | 308 | |
| Operating Profit | -16 | 159 | 101 | |
| OPM % | -16% | 28% | 25% | |
| Other Income | 1 | 5 | 3 | |
| Interest | 4 | 12 | 11 | |
| Depreciation | 12 | 20 | 17 | |
| Profit before tax | -31 | 132 | 76 | |
| Tax % | -23% | 27% | 31% | |
| Net Profit | -24 | 96 | 53 | |
| EPS in Rs | -10.51 | 8.06 | 5.21 | |
| Raw PDF |
Earnings
Results dates & reactionsFresh quarters land in the Financials table above, tagged NSE until screener catches up.
| Q1FY27† | |
|---|---|
| Broadcast | 5 Sept '26◦ |
| Earnings day | −2.87% |
| +1 day | −3.71% |
| +5 days | +16.92% |
| +15 days | +8.19% |
| +30 days | +8.55% |
| Filing | XBRL |
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Results analysis
Shareholding
as of Aug 2026Peers
7 companies| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Poly Medicure | ₹1,726.00 | 54.67 | 17,495 | 0.20% | 85 | −7.57% | 525 | +30.30% | 12.50% |
| Molbio Diagnosti | ₹1,288.30 | 59.47 | 14,846 | 0.00% | 53 | +347.79% | 408 | +309.57% | 18.48% |
| Fischer Medical | ₹33.15 | 94.61 | 2,316 | 0.15% | 4 | −22.02% | 82 | +249.49% | 11.38% |
| Tarsons Products | ₹306.10 | 137.55 | 1,629 | 0.00% | −1 | −180.90% | 110 | +20.67% | 4.59% |
| Q-Line Biotech | ₹696.95 | 28.79 | 1,626 | 0.00% | 34 | +147.29% | 198 | −8.59% | 22.46% |
| Laxmi Dental | ₹197.95 | 31.32 | 1,089 | 0.00% | 10 | +22.77% | 75 | +13.87% | 15.05% |
| Vasa Denticity | ₹420.40 | 60.26 | 729 | 0.00% | 4 | +45.99% | 82 | +36.90% | 9.21% |
| Median: 17 Co. | ₹342.40 | 33.09 | 603 | 0.00% | 4 | +19.77% | 75 | +21.48% | 15.14% |
